| Challenges associated with hypertensive disease during pregnancy in low-income countries. | |
| | |
MedLine Citation:
|
PMID: 20362990 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To assess the challenges associated with the diagnosis, management, and prevention of hypertensive disease during pregnancy in low-income countries, following the success of the Magpie Trial. METHODS: Descriptive review of the literature from 1990 to 2009 on the diagnosis, management, and prevention of hypertensive disease in pregnancy. RESULTS: In the absence of credible measures to predict and prevent hypertension in pregnancy, diagnosis and treatment remain the only viable options, although they are still associated with important challenges in low-income countries. Despite the presence of high-quality evidence that magnesium sulfate is safe and effective at preventing and treating eclampsia, its use is extremely limited in many low-income countries. CONCLUSION: There is a need for cheap and reliable tools with which to address the diagnostic, preventive, and management challenges associated with hypertensive disease during pregnancy in low-income countries. It is recommended that such countries incorporate magnesium sulfate protocols into their national health and/or practice policies. |
| | |
Authors:
|
Kwabena A Danso; Henry S Opare-Addo |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-04-02 |
Journal Detail:
|
Title: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Volume: 110 ISSN: 1879-3479 ISO Abbreviation: Int J Gynaecol Obstet Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-08-04 Completed Date: 2010-11-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0210174 Medline TA: Int J Gynaecol Obstet Country: Ireland |
Other Details:
|
Languages: eng Pagination: 78-81 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Department of Obstetrics and Gynaecology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. kadanso1443@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticonvulsants
/
adverse effects,
therapeutic use Antihypertensive Agents / adverse effects, therapeutic use* Developing Countries Eclampsia / drug therapy, prevention & control Female Humans Hypertension, Pregnancy-Induced / diagnosis, drug therapy*, prevention & control Magnesium Sulfate / adverse effects, therapeutic use* Pregnancy |
| Chemical | |
Reg. No./Substance:
|
0/Anticonvulsants; 0/Antihypertensive Agents; 7487-88-9/Magnesium Sulfate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveri...
Next Document: Factors associated with failure to achieve birth emphasizing a successful singleton at term followin...